A Thorough Understanding of the Cellular Origin of Glioma Relies on Multidisciplinary Approaches Malignant glioma is the most common primary brain tumor. Despite its relatively low occurrence ...

Glioblastoma, an aggressive form of brain cancer, originates in the brain's supportive tissue, known as glial cells. It is ...

Sep. 20, 2024 — Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in the dreaded glioblastoma -- at least ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Brain Tumor InfoCon will take place on October 8, 2024 from 7:00 PM to 8:00 PM. It will feature six presentations, followed ...

Glioma is a leading cause of global mortality as the most common primary malignant brain tumor in adults, accounting for over 60% of all intracranial primary tumors. Glioblastoma is known as the most ...

U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has earned an NIH fast-track ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor. The therapy uses genetically modified T cells to target a specific marker on tumor ...

Also, they don’t often cause symptoms unless they become very large or develop in sensitive body parts, such as the nervous system (the brain, spinal cord, and nerves). Tumors can develop and spread ...

Sun Pharma has signed a global licensing deal with Philogen to commercialize Fibromun, an anti-cancer treatment currently in ...

the two major cells found in glioblastoma, a fast-moving brain cancer that resists traditional treatment protocols. Back To Top ...